Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2011-08-03
Original market date: See footnote 1
1974-12-31
Product name:
TERFLUZINE-1
DIN:
00294861 Electronic product monograph is not available
Company:
VALEANT CANADA LP / VALEANT CANADA S.E.C.
2150 Boul. St-Elzear Ouest
Laval
Quebec
Canada
H7L 4A8
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:16.08.24
Anatomical Therapeutic Chemical (ATC): See footnote 4
N05AB06 TRIFLUOPERAZINE
Active ingredient group (AIG) number:See footnote5
0131362001
Active ingredient(s) See footnote8 | Strength |
---|---|
TRIFLUOPERAZINE (TRIFLUOPERAZINE HYDROCHLORIDE) | 1 MG |